PCH
JBIO

Polar Capital Holdings’s Jade Biosciences JBIO Stock Holding History

Polar Capital Holdings’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41M Buy
+1,846,982
New +$38.5M 0.1% 137

Other funds holding JBIO

JTL
Jupiter Topco LLC New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Polar Capital Holdings's JBIO Position: Q2 2026 in Review

Polar Capital Holdings opened a new position in Jade Biosciences (JBIO) in Q2 2026: 1,846,982 shares worth $41M. The stake represents 0.1% of the portfolio and ranks #137 among its holdings.

141 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Polar Capital Holdings held 1,846,982 shares of Jade Biosciences worth $41M as of Q2 2026.
  • Jade Biosciences was a new Polar Capital Holdings position in Q2 2026.
  • Jade Biosciences made up 0.1% of Polar Capital Holdings's portfolio in Q2 2026, its #137 holding.
  • 141 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.